CELZ logo

CELZ Stock Overview

Profile

Full Name:

Creative Medical Technology Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 6, 2015

Indexes:

Not included

Website:

http://www.creativemedicaltechnology.com

Description:

Creative Medical Technology Holdings (CELZ) focuses on developing innovative therapies using stem cells and regenerative medicine. The company aims to treat various medical conditions, including neurological disorders and erectile dysfunction, by harnessing the body's natural healing processes to improve patient outcomes and quality of life.

Key Details

Price

$6.60

Market Cap

$11.54 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9000.00(-89.84% YoY)

Annual EPS

-$3.76(+59.48% YoY)

PE Ratio

-

Annual ROE

-40.34%

Annual Debt To Equity

0.00

Beta

0.79

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 12, 2023

Analyst ratings

Recent major analysts updates

Feb 25, 22 Roth Capital
Buy

Screeners with CELZ included

Growing Shares Outstanding
US stocks
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Best performing stocks YTD

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$6.60
CELZ price is $6.60

Price All-time High

$487500.00
CELZ price is currently -100.00% below its historical high of $487500.00

Price Analysts Target

$30.00
CELZ price is currently -78.00% lower than the consensus analysts' forecast

Price Today Change

+4.43%
CELZ price is up +4.43% today

Price YTD Change

+193.33%
CELZ price is up +193.33% since January 1st

Price 3-Year Change

-60.48%
CELZ price is down -60.48% over the past 3 years

Market cap

Market Cap

$11.54 M
CELZ market capitalization is $11.54 million

Market Cap 3-Year Change

+9.01%
CELZ market capitalization is up +9.01% over the past 3 years

Market Cap All-time High

$69.17 M
CELZ market capitalization is currently -83.32% below its historical high of $69.17 million

Market Cap Sector Rank

19.59%
CELZ market capitalization is higher than 19.59% of companies in Healthcare sector

Technical

Beta

0.79
CELZ beta is 0.79

200-day SMA

$3.44
CELZ price is currently +91.69% above its 200-day simple moving average

14-day RSI

72.04
CELZ 14-day relative strength index is 72.04

30-day Relative Volume

1.38
CELZ 30-day relative volume is 1.38

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$9000.00
CELZ annual revenue is $9000.00

Annual Revenue Analysts Estimate

-
CELZ annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-89.84%
CELZ annual revenue is down -89.84% year-on-year

Annual Revenue Sector Rank

4.3%
CELZ annual revenue is higher than 4.3% of companies in Healthcare sector

Profit

Annual Gross Profit

$5400.00
CELZ annual gross profit is $5400.00

Annual Gross Margin

60.00%
CELZ annual gross profit margin is 60.00%

Annual Operating Profit

-$5.62 M
CELZ annual operating income is -$5.62 million

Annual Operating Margin

-62.45 K%
CELZ annual operating profit margin is -62.45 thousand%

Annual Net Income

-$5.29 M
CELZ annual net profit is -$5.29 million

Annual Net Margin

-58.74 K%
CELZ annual net profit margin is -58.74 thousand%

EPS

Annual EPS

-$3.76
CELZ annual earnings per share is -$3.76

Annual EPS Analysts Estimate

-$3.19
CELZ annual earnings per share is currently +17.87% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+59.48%
CELZ annual earnings per share is up +59.48% year-on-year

Annual EPS Sector Rank

28.21%
CELZ annual earnings per share is higher than 28.21% of companies in Healthcare sector

ROA & ROE

Annual ROA

-35.36%
CELZ annual return on assets is -35.36%

Annual ROE

-40.34%
CELZ annual return on equity is -40.34%

EBIT & EBITDA

Annual EBIT

-$5.62 M
CELZ annual earnings before interest & taxes is -$5.62 million

Annual EBITDA

-$5.53 M
CELZ annual EBITDA is -$5.53 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CELZ price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CELZ price to earnings ratio is unknown

PB Ratio

PB Ratio

1.76
CELZ price to book ratio is 1.76

PB Ratio Sector Rank

56.19%
CELZ price to book ratio is higher than 56.19% of companies in Healthcare sector

PS Ratio

PS Ratio

-
CELZ price to sales ratio value is unknown

PS Ratio Sector Rank

-
CELZ price to sales ratio is unknown

Enterprise value

Enterprise Value

$5.28 M
CELZ enterprise value is $5.28 million

Enterprise Value Sector Rank

19.05%
CELZ enterprise value is higher than 19.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.97
CELZ EV/EBITDA is -0.97

EV/EBITDA Sector Rank

45.98%
CELZ EV/EBITDA is higher than 45.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

27.66
CELZ annual current ratio is 27.66

Annual Quick Ratio

27.64
CELZ annual quick ratio is 27.64

Leverage

Annual Debt To Equity

0.00
CELZ annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
CELZ annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CELZ piotroski f-score value is unknown

Altman Z-Score

10.30
CELZ altman z-score is 10.30

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$10.72 M
CELZ annual total assets is $10.72 million

Annual Non Current Assets

$444.30 K
CELZ annual long term assets is $444.30 thousand

Annual Current Assets

$10.27 M
CELZ annual total current assets is $10.27 million

Annual Cash & Cash Equivalents

$3.47 M
CELZ annual cash & cash equivalents is $3.47 million

Equity

Annual Book Value

$10.34 M
CELZ annual book value is $10.34 million

Annual Working Capital

$9.90 M
CELZ annual working capital is $9.90 million

Liabilities

Annual Total Liabilities

$371.40 K
CELZ annual total liabilities is $371.40 thousand

Annual Total Long Term Liabilities

$0.00
CELZ annual total long term liabilities is $0.00

Annual Current Liabilities

$371.40 K
CELZ annual total current liabilities is $371.40 thousand

Annual Accounts Payable

$317.30 K
CELZ annual accounts payable is $317.30 thousand

Debt

Annual Total Debt

$0.00
CELZ annual total debt is $0.00

Annual Total Debt 1-Year Change

0%
CELZ {parameterFullLabel} has remained unchanged year-on-year

Annual Long Term Debt

-
CELZ annual long term debt value is unknown

Annual Short Term Debt

-
CELZ annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$5.63 M
CELZ annual total expenses is $5.63 million

Annual Operating Expenses

$5.63 M
CELZ annual total operating expenses is $5.63 million

Annual Cost Of Goods Sold

$3600.00
CELZ annual cost of goods sold is $3600.00

Annual SGA

$3.56 M
CELZ annual SGA is $3.56 million

Annual D&A

$94.60 K
CELZ annual depreciation & amortization is $94.60 thousand

Annual Interest Expense

-
CELZ annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$8.03 M
CELZ annual cash flow from operations is -$8.03 million

Annual CFO 1-Year Change

-2.96%
CELZ annual cash flow from operations is down -2.96% year-on-year

Annual CFI

$3.45 M
CELZ annual cash flow from investing activities is $3.45 million

Annual CFI 1-Year Change

+134.18%
CELZ annual cash flow from investing activities is up +134.18% year-on-year

Annual CFF

-$271.00 K
CELZ annual cash flow from financing activities is -$271.00 thousand

Annual CFF 1-Year Change

-101.75%
CELZ annual cash flow from financing activities is down -101.75% year-on-year

Free CashFlow

Annual FCF

-$8.13 M
CELZ annual free cash flow is -$8.13 million

Annual FCF 1-Year Change

-4.24%
CELZ annual free cash flow is down -4.24% year-on-year

CAPEX

Annual CAPEX

$100.00 K
CELZ annual capital expenditures is $100.00 thousand

Annual CAPEX 1-Year Change

-
CELZ annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

NERV logo
Minerva Neurosciences (NERV)
SNSE logo
Sensei Biotherapeutics (SNSE)
PHGE logo
BiomX (PHGE)
INBS logo
Intelligent Bio Solutions (INBS)
SSKN logo
STRATA Skin Sciences (SSKN)
BCDA logo
BioCardia (BCDA)
BCTX logo
BriaCell Therapeutics (BCTX)
BLRX logo
BioLineRx (BLRX)
ACXP logo
Acurx Pharmaceuticals (ACXP)

FAQ

  • What is the ticker symbol for Creative Medical Technology Holdings?
  • Does Creative Medical Technology Holdings pay dividends?
  • What sector is Creative Medical Technology Holdings in?
  • What industry is Creative Medical Technology Holdings in?
  • What country is Creative Medical Technology Holdings based in?
  • When did Creative Medical Technology Holdings go public?
  • Is Creative Medical Technology Holdings in the S&P 500?
  • Is Creative Medical Technology Holdings in the NASDAQ 100?
  • Is Creative Medical Technology Holdings in the Dow Jones?
  • When does Creative Medical Technology Holdings report earnings?
  • Should I buy Creative Medical Technology Holdings stock now?

What is the ticker symbol for Creative Medical Technology Holdings?

The ticker symbol for Creative Medical Technology Holdings is NASDAQ:CELZ

Does Creative Medical Technology Holdings pay dividends?

No, Creative Medical Technology Holdings does not pay dividends

What sector is Creative Medical Technology Holdings in?

Creative Medical Technology Holdings is in the Healthcare sector

What industry is Creative Medical Technology Holdings in?

Creative Medical Technology Holdings is in the Biotechnology industry

What country is Creative Medical Technology Holdings based in?

Creative Medical Technology Holdings is headquartered in United States

When did Creative Medical Technology Holdings go public?

Creative Medical Technology Holdings's initial public offering (IPO) was on November 6, 2015

Is Creative Medical Technology Holdings in the S&P 500?

No, Creative Medical Technology Holdings is not included in the S&P 500 index

Is Creative Medical Technology Holdings in the NASDAQ 100?

No, Creative Medical Technology Holdings is not included in the NASDAQ 100 index

Is Creative Medical Technology Holdings in the Dow Jones?

No, Creative Medical Technology Holdings is not included in the Dow Jones index

When does Creative Medical Technology Holdings report earnings?

The date for Creative Medical Technology Holdings's next earnings report has not been announced yet

Should I buy Creative Medical Technology Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions